BIIB Biogen Inc.
Biogen Inc. (BIIB) Hedge Fund Activity
This view isolates hedge funds from the broader institutional ownership shown on the Institutional tab. A pension fund tracking an index may have no view on a stock; when a hedge fund builds or exits a position, that decision can carry information. This page measures those changes. Positions as of June 30, 2026.
Based on quarterly 13F long-equity filings. Changes compare reported quarter-end positions; filings can be reported up to 45 days later and do not represent a fund's complete exposure.
Most significant moves
Ranked by conviction, not size — how much of the fund's own book the position represents, how far it moved, and what kind of fund made it.
| Fund | Action | Shares changed | Change | Est. value | Portfolio wt. | Score |
|---|---|---|---|---|---|---|
| Perceptive Advisors Growth Healthcare | New | +276.2K | — | $59.7M | 0.9% | 71 |
| Logos Global Management Growth Healthcare | Sold Out | -200.0K | -100.0% | $43.2M | 0.0% | 69 |
| Farallon Capital Management Event Value | New | +71.0K | — | $15.3M | 0.1% | 64 |
| Glenview Capital Management Long/Short Value | Sold Out | -57.0K | -100.0% | $12.3M | 0.0% | 63 |
| D. E. Shaw & Co., Inc. Quant | New | +74.4K | — | $16.1M | 0.0% | 62 |
| MILLENNIUM MANAGEMENT LLC | Sold Out | -94.0K | -100.0% | $20.3M | 0.0% | 61 |
| Point72 Asset Management, L.P. | Reduced | -721.5K | -89.1% | $155.9M | 0.0% | 60 |
| Qube Research & Technologies Ltd Quant | Sold Out | -212.9K | -100.0% | $46.0M | 0.0% | 59 |
| Tang Capital Management Growth Healthcare | Sold Out | -35.0K | -100.0% | $7.6M | 0.0% | 59 |
| CITADEL ADVISORS LLC Quant | Increased | +280.3K | +203.0% | $60.6M | 0.1% | 58 |
Most significant buyers
By move score, not size.
- Perceptive Advisors
- Farallon Capital Management
- D. E. Shaw & Co., Inc.
- CITADEL ADVISORS LLC
- Verition Fund Management
Most significant sellers
By move score, not size.
- Logos Global Management
- Glenview Capital Management
- MILLENNIUM MANAGEMENT LLC
- Point72 Asset Management, L.P.
- Qube Research & Technologies Ltd
Hedge fund positions
| Fund | Tier | Shares | Previous | Change | Change % | Portfolio wt. | Action | Score |
|---|---|---|---|---|---|---|---|---|
| Perceptive Advisors | 1 | 276.2K | 0 | +276.2K | — | 0.9% | New | 71 |
| Logos Global Management | 2 | 0 | 200.0K | -200.0K | -100.0% | 0.0% | Sold Out | 69 |
| Farallon Capital Management | 1 | 71.0K | 0 | +71.0K | — | 0.1% | New | 64 |
| Glenview Capital Management | 2 | 0 | 57.0K | -57.0K | -100.0% | 0.0% | Sold Out | 63 |
| D. E. Shaw & Co., Inc. | 1 | 74.4K | 0 | +74.4K | — | 0.0% | New | 62 |
| MILLENNIUM MANAGEMENT LLC | 2 | 0 | 94.0K | -94.0K | -100.0% | 0.0% | Sold Out | 61 |
| Point72 Asset Management, L.P. | 1 | 88.1K | 809.6K | -721.5K | -89.1% | 0.0% | Reduced | 60 |
| Qube Research & Technologies Ltd | 2 | 0 | 212.9K | -212.9K | -100.0% | 0.0% | Sold Out | 59 |
| Tang Capital Management | 2 | 0 | 35.0K | -35.0K | -100.0% | 0.0% | Sold Out | 59 |
| CITADEL ADVISORS LLC | 1 | 418.4K | 138.1K | +280.3K | +203.0% | 0.1% | Increased | 58 |
| Verition Fund Management | 2 | 30.9K | 0 | +30.9K | — | 0.1% | New | 56 |
| Schonfeld Strategic Advisors | 3 | 0 | 48.8K | -48.8K | -100.0% | 0.0% | Sold Out | 55 |
| MARSHALL WACE, LLP | 2 | 12.6K | 229.9K | -217.3K | -94.5% | 0.0% | Reduced | 53 |
| Caption Management | 3 | 21.0K | 0 | +21.0K | — | 0.2% | New | 53 |
| Graham Capital Management | 3 | 0 | 10.3K | -10.3K | -100.0% | 0.0% | Sold Out | 52 |
| LMR Partners | 3 | 4.9K | 116.1K | -111.3K | -95.8% | 0.0% | Reduced | 51 |
| Alphadyne Asset Management | 3 | 0 | 1.2K | -1.2K | -100.0% | 0.0% | Sold Out | 51 |
| ExodusPoint Capital Management | 3 | 2.9K | 152.0K | -149.1K | -98.1% | 0.0% | Reduced | 51 |
| CenterBook Partners | 4 | 10.4K | 0 | +10.4K | — | 0.1% | New | 51 |
| Boothbay Fund Management | 4 | 0 | 14.3K | -14.3K | -100.0% | 0.0% | Sold Out | 51 |
| Cinctive Capital Management | 3 | 72.8K | 19.3K | +53.4K | +276.2% | 0.7% | Increased | 51 |
| Winton Group | 4 | 0 | 3.3K | -3.3K | -100.0% | 0.0% | Sold Out | 48 |
| Balyasny Asset Management L.P. | 2 | 265.1K | 650.0K | -385.0K | -59.2% | 0.1% | Reduced | 48 |
| Integral Health Asset Management | 2 | 100.0K | 60.0K | +40.0K | +66.7% | 0.9% | Increased | 48 |
| Engineers Gate | 4 | 0 | 1.6K | -1.6K | -100.0% | 0.0% | Sold Out | 48 |
| RENAISSANCE TECHNOLOGIES LLC | 1 | 77.7K | 203.4K | -125.7K | -61.8% | 0.0% | Reduced | 47 |
| Walleye Capital | 3 | 569 | 35.3K | -34.8K | -98.4% | 0.0% | Reduced | 47 |
| Palo Alto Investors | 2 | 140.3K | 140.7K | -440 | -0.3% | 4.4% | Reduced | 46 |
| Squarepoint Ops LLC | 2 | 7.0K | 36.1K | -29.0K | -80.6% | 0.0% | Reduced | 46 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2 | 129.6K | 333.5K | -203.9K | -61.1% | 0.0% | Reduced | 44 |
| Lighthouse Investment Partners | 3 | 7.5K | 32.6K | -25.1K | -77.0% | 0.1% | Reduced | 42 |
| Hudson Bay Capital Management | 3 | 90.0K | 201.4K | -111.4K | -55.3% | 0.1% | Reduced | 41 |
| ADAR1 Capital Management | 3 | 17.9K | 11.0K | +6.9K | +62.7% | 0.2% | Increased | 41 |
| Alyeska Investment Group, L.P. | 2 | 932.4K | 805.1K | +127.3K | +15.8% | 0.6% | Increased | 36 |
| Man Group | 3 | 196.2K | 318.7K | -122.5K | -38.4% | 0.1% | Reduced | 35 |
| Portolan Capital Management | 3 | 142.9K | 118.5K | +24.4K | +20.6% | 1.2% | Increased | 34 |
| TWO SIGMA INVESTMENTS, LP | 2 | 7.1K | 9.4K | -2.3K | -24.8% | 0.0% | Reduced | 32 |
| Gotham Asset Management, LLC | 2 | 279.9K | 298.4K | -18.5K | -6.2% | 0.2% | Reduced | 28 |
| Parallax Volatility Advisers | 3 | 2.3K | 1.7K | +602 | +35.6% | 0.0% | Increased | 28 |
| Woodline Partners LP | 2 | 112.5K | 109.0K | +3.4K | +3.1% | 0.1% | Increased | 24 |
| AQR Capital Management | 3 | 1.9M | 1.9M | +13.3K | +0.7% | 0.1% | Increased | 23 |
| OrbiMed Advisors | 2 | 61.6K | 61.6K | 0 | +0.0% | 0.3% | Unchanged | 22 |
| Holocene Advisors, LP | 2 | 4.8K | 4.8K | 0 | +0.0% | 0.0% | Unchanged | 20 |
Every fund above opens. Subscribers can see any manager's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeHedge funds are identified from their 13F filings, which are due 45 days after quarter end and cover long U.S.-listed equity positions only. A fund's short book never appears, so a reduced position can mean a changed view or a changed hedge — the filing doesn't say which.